Table 2 Proportion of patients in groups 2 and 3 with upregulated expression of the indicated cluster 5 genes
Resectable (%) | Metastatic (%) | |||
---|---|---|---|---|
Genea | Group 2 | Group 3 | Group 2 | Group 3 |
GSDMD | 15 | 57 | 15 | 33 |
KLF2 | 3 | 78 | 0 | 83 |
RIPK3 | 9 | 65 | 0 | 58 |
SRC | 15 | 68 | 31 | 50 |
CARD11 | 12 | 59 | 8 | 50 |
LDLR | 0 | 59 | 0 | 75 |
MAPK3 | 12 | 62 | 15 | 25 |